Oncotelic Therapeutics (OTLC) has released an update to notify the public and investors about an entry into a material definitive agreement.
The text provides an overview of a situation where legal action is being taken due to the violation of a non-compete clause. The involved parties are in dispute over the unauthorized use of proprietary information, which has led to the initiation of litigation to resolve the matter and seek appropriate remedies.
For further insights into OTLC stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
